Drug Profile
Naproxen sodium/metoclopramide - POZEN
Alternative Names: Metoclopramide/naproxen-sodium; MT 100; Naproxen-sodium/metoclopramideLatest Information Update: 30 Nov 2005
Price :
$50
*
At a glance
- Originator POZEN
- Class Aminobenzoic acids; Antiemetics; Antimigraines; Antipyretics; Benzamides; Chlorobenzenes; Diethylamines; Gastrokinetics; Naphthaleneacetic acids; Nonsteroidal anti-inflammatories; Phenyl ethers; Small molecules
- Mechanism of Action Cyclooxygenase inhibitors; Dopamine receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Registered Migraine
Most Recent Events
- 28 Nov 2005 Registered for Migraine in United Kingdom (PO)
- 05 Aug 2005 Withdrawn - Preregistration for Migraine in USA (PO)
- 03 Mar 2005 A Committee on Safety of Medicines to the Medicines and Healthcare Products Regulatory Agency (MHRA) in the United Kingdom agreed to advise the MHRA that the MAA be granted for naproxen sodium/metoclopramide